| 2025-11-07 | Biotech | patentscope.wipo.int | In vivo gene editing with CRISPR systems | Available |
| 2025-11-04 | Biotech | patentscope.wipo.int | Gene therapy (AAV particle) methods | Available |
| 2025-10-28 | Biotech | patentscope.wipo.int | Cell‑type‑specific delivery of gene editors | Available |
| 2025-10-25 | Biotech | patentscope.wipo.int | Gene therapy for GRIN disorders | Available |
| 2025-10-24 | Biotech | patentscope.wipo.int | CRISPR/Cas9 exon-skipping for USH2A retinal disease | Available |
| 2025-10-22 | Biotech | patentscope.wipo.int | SERS biosensor using CRISPR/Cas13a | Available |
| 2025-10-18 | Biotech | patentscope.wipo.int | CRISPR-Cas systems (engineered effectors) | Available |
| 2025-10-16 | Biotech | openalex.org | OpenAlex query: CRISPR base editing 2025 site:openalex.org | Available |
| 2025-10-13 | Biotech | patentscope.wipo.int | ENPP1 gene therapy for vascular disease | Available |
| 2025-10-09 | Biotech | openalex.org | OpenAlex query: protein design diffusion models 2025 | Available |
| 2025-10-07 | Biotech | patentscope.wipo.int | Gene therapy for MTRES1‑related diseases | Available |
| 2025-10-01 | Biotech | patentscope.wipo.int | Cytotoxic synergy of CRISPR‑Cas9 with DDR inhibitors | Available |
| 2025-10-01 | Biotech | patentscope.wipo.int | TNNT2 modulation gene therapy for cardiomyopathy | Available |
| 2025-10-01 | Biotech | openalex.org | OpenAlex query: RNA therapeutics delivery 2025 site:openalex.org | Available |
| 2025-09-23 | Biotech | ir.compasspathways.com | COMPASS Pathways FDA submission for psilocybin therapy COMP360 | Available |
| 2025-09-12 | Biotech | pubmed.ncbi.nlm.nih.gov | In vivo Precision Base Editing to Rescue Mouse Disease Models | Available |
| 2025-09-08 | Biotech | www.colossal.com | Colossal Biosciences successfully births first "proxy mammoth" hybrid calf | Available |
| 2025-09-05 | Biotech | pubmed.ncbi.nlm.nih.gov | Next‑Gen CRISPR Tools in Neurodegeneration | Available |
| 2025-08-11 | Biotech | www.thelancet.com | Neuroprosthesis enables paralyzed patient to walk with thought-controlled exoskeleton | Available |
| 2025-07-22 | Biotech | pubmed.ncbi.nlm.nih.gov | CRISPR‑BEasy: sgRNA Library Design for Base‑Editing Screens | Available |
| 2025-06-21 | Biotech | www.nature.com | Altos Labs publishes partial reprogramming longevity results in primates | Available |
| 2025-06-18 | Biotech | patentscope.wipo.int | Engineered CRISPR‑Cas12 systems | Available |
| 2025-06-15 | Biotech | pubmed.ncbi.nlm.nih.gov | Base Editing Therapeutic Strategy Review | Available |
| 2025-06-15 | Biotech | pubmed.ncbi.nlm.nih.gov | CRISPR‑Dependent Base Editing as a Therapeutic Strategy | Available |
| 2025-05-04 | Biotech | www.fda.gov | precisionFDA approves first AI-designed monoclonal antibody for human trials | Available |
| 2025-05-01 | Biotech | www.cell.com | In vivo CAR-T administered via LNPs shows lymphoma remission in 5 patients | Available |
| 2025-04-17 | Biotech | www.nature.com | Organoid Intelligence achieves biocomputing milestone with neuronal learning | Available |
| 2025-04-11 | Biotech | www.synchron.com | Synchron's brain-computer interface achieves at-home use in 15 ALS patients | Available |
| 2025-04-06 | Biotech | patentscope.wipo.int | Class 2 type V CRISPR prime editing toolkit | Available |
| 2025-03-21 | Biotech | pubmed.ncbi.nlm.nih.gov | Advancing CRISPR Editing into Gene Therapy: Clinical Applications | Available |
| 2025-03-14 | Biotech | www.4dmt.com | 4D Molecular Therapeutics gene therapy shows durable expression at 5 years | Available |
| 2025-02-28 | Biotech | pubmed.ncbi.nlm.nih.gov | ABE Precision via Expanded Cas9 PAM | Available |
| 2025-02-28 | Biotech | pubmed.ncbi.nlm.nih.gov | Improving Adenine Base Editing Precision via Expanded Cas9 PAM | Available |
| 2025-02-16 | Biotech | vertex.com | Vertex's CRISPR-based pain therapy enters clinic; non-opioid alternative | Available |
| 2025-02-15 | Biotech | www.ginkgobioworks.com | Ginkgo Bioworks partners with DARPA to engineer bacteria for rare earth extraction | Available |
| 2025-02-06 | Biotech | www.primemedicine.com | Prime Medicine's "PASSIGE" gene editing enters clinic for Wilson disease | Available |
| 2024-12-08 | Biotech | investors.modernatx.com | Moderna/Merck mRNA-4157 posts Phase 3 melanoma survival data | Available |
| 2024-11-11 | Biotech | www.beamtx.com | Base Editing therapy enters Ph2 for PCSK9 | Available |
| 2024-07-13 | Biotech | www.fda.gov | Eli Lilly donanemab receives full FDA approval for early Alzheimer's | Available |
| 2024-01-05 | Biotech | apnews.com | Neuralink’s first human implant (Telepathy) | Available |
| 2024-01-04 | Biotech | www.fda.gov | CASGEVY gets second FDA indication (TDT) | Available |
| 2023-12-27 | Biotech | www.fda.gov | FDA approves first CRISPR therapy (Casgevy) | Available |